Bioreactors Market outlook with industry review and forecasts
Category: #business  By Rahul Varpe  Date: 2020-01-16
  • share
  • Twitter
  • Facebook
  • LinkedIn
Bioreactors Market outlook with industry review and forecasts

Growing focus on R&D in biotechnology and increasingly rising chronic disorders are outlined as the prime drivers behind bioreactors market growth. The investments in the biopharmaceutical sector are soaring as demand for product innovation, and effective therapeutic vaccines are on a constant rise. Besides, favorable government initiatives to expand and improve healthcare infrastructure will further provide an impetus to bioreactors market. The surging precision medicine market has impelled personalized medical treatments for the patients, which, in turn, will favor the growth of bioreactor industry. As per the report compiled by Global Market Insights, Inc., the Global Bioreactor Industry is estimated to register 18% CAGR over the period of 2016-2024.

Progressing tissue engineering technologies, development of orphan drugs, and growing antibodies production are also identified as the typical trends which are significantly driving the bioreactors market share. Biopharma manufacturers, CMOs (Contract manufacturing organizations) and R&D organizations are the three predominant end-use industries in the worldwide bioreactor market. Holding more than 30% of overall bioreactor industry share in 2016, biopharmaceutical manufacturers have enabled effective drug delivery systems and combination products. The bioreactor industry is likely to spectate growing collaborations in biopharmaceutical sector through strategic partnerships with diagnostic developers, medical device manufacturers, and even academic institutions.

Request sample copy of this report @ http://decresearch.com/request-sample/detail/141

One such example is of Sartorius Stedim Biotech, a leading global supplier in the biopharmaceutical industry acquisition of U.S. start-up kSep Holdings, Inc. in 2016.  kSep Systems leverages its innovation and engineering expertise to develop automated centrifugation systems which are widely used in manufacturing of monoclonal antibodies, cell-based therapeutics, and vaccines. This USD 28 million deal successfully expanded Sartorius’ bioprocessing solutions portfolio.

The growing number of pharmaceutical companies and technological advancements in the medical space is driving the U.S. bioreactor market size, slated to cross an industry valuation of USD 600 million by 2024. Germany bioreactor market accounted for more than 25% of Europe share and is anticipated to grow substantially over the years ahead, with the presence of leading industry players, favorable governmental policies, and rising healthcare expenditures.

Based on technology, bioreactor market is segmented into single use bubble column, wave-induced motion SUB, and stirred SUB technology. Accounting for more than one half of the global bioreactor industry share, the wave-induced motion SUB technology represents the biggest technological segment. Stirred SUBs is also set to accelerate its business with its growing demand in biopharmaceutical industry. Stirred SUBs market is anticipated to record more than 18% CAGR over the period of 2016-2024.

Request for discount @ http://decresearch.com/request-discount/141

China bioreactor industry driven by rising prevalence of chronic diseases and increasing R&D investment in the region is further expected to record an annual growth rate of 19% over the time span of 2016-2024. An overall shift from traditional methods to new production techniques of monoclonal antibodies, cell culturing, and recombinant proteins will keep Asia Pacific bioreactor market growth perpetual.

The monoclonal antibodies occupied over 35% of the overall industry share by collecting revenue worth USD 190 million in 2016. Increasing application of the monoclonal antibodies molecule in the treatment of asthma, leukemia, breast cancers, etc. have attributed to the segment’s growth.

Taking into account the bioreactor market bifurcation based on type of cells, mammalian cells held over 75% of industry share. Furthermore, the yeast cells demand is projected to record a CAGR of 15% over the period of 2016-2024. Increasing research activities is likely to expand the business for bioreactors.

Get In-depth table of contents @ http://decresearch.com/toc/detail/bioreactor-market

Eppendorf, Sartorius, GE Healthcare, Thermo Fisher Scientific, and Merck Millipore are some of the prominent players in bioreactor industry.

Table Of Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Bioreactors industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Cell trends

2.1.3. Molecule trends

2.1.4. Technology trends

2.1.5. End-use trends

2.1.6. Regional trends

Chapter 3. Bioreactors Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry ecosystem analysis

3.3.1. Distribution channel analysis

3.3.2. Vendor matrix

3.4. Regulatory Landscape

3.4.1. U.S.

3.4.2. Canada

3.4.3. Germany

3.4.4. UK

3.4.5. China

3.5. Industry impact forces

3.5.1. Growth drivers

3.5.1.1. Growing biopharmaceuticals and biologics industry

3.5.1.2. Technological advancements in bioreactors

3.5.1.3. Growing orphan drugs developments

3.5.1.4. Increasing demand for personalized medicines

3.5.2. Industry pitfalls & challenges

3.5.2.1. Low capacity of single-use bioreactor

3.5.2.2. Concerns regarding extractables and/or leachables

3.6. Growth potential analysis

3.6.1. By cell

3.6.2. By molecule

3.6.3. By technology

3.6.4. By end-use

3.7. Outsourcing landscape

3.8. Technology landscape

3.8.1. U.S.

3.8.2. Europe

3.9. Porter’s analysis

3.10. Competitive landscape, 2017

3.10.1. Strategy dashboard

3.11. PESTEL analysis

Chapter 4. Bioreactors Market, by Cell

4.1. Key segment trends

4.2. Mammalian cells

4.2.1. Market estimates and forecast, by region, 2014 - 2025

4.3. Bacterial cells

4.3.1. Market estimates and forecast, by region, 2014 - 2025

4.4. Yeast cells

4.4.1. Market estimates and forecast, by region, 2014 – 2025

4.5. Others

4.5.1. Market estimates and forecast, by region, 2014 - 2025

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Rahul Varpe

Rahul Varpe    

Rahul Varpe currently writes for Technology Magazine. A communication Engineering graduate by education, Rahul started his journey in as a freelancer writer along with regular jobs. Rahul has a prior experience in writing as well as marketing of services and products ...

Read More >>

More News By Rahul Varpe

Food Antioxidant market Witness Highest Growth In Near Future
Food Antioxidant market Witness Highest Growth In Near Future
By Rahul Varpe

Market Overview: – The global Food Antioxidant market is valued at 2.5 Billion USD in 2018, At CAGR of 4.7% and is expected to reach 2.5 Billion USD by the end of 2025. Decresearch has released a brief analysis, see at on Global Food Antioxid...

Flavouring Agents Market 2020 Global Analysis, Trends, Forecast Up To 2026
Flavouring Agents Market 2020 Global Analysis, Trends, Forecast Up To 2026
By Rahul Varpe

Market Overview: – The global Flavouring Agents market is valued at 15 Billion USD in 2018, At CAGR of 4.5% and is expected to reach 21.2 Billion USD by the end of 2025. Decresearch has released a brief analysis, see at on Global Flavouring A...

Infant Formula Market 2020-2026 global outlook on key growth trends, factors
Infant Formula Market 2020-2026 global outlook on key growth trends, factors
By Rahul Varpe

Market Overview: – The global Infant Formula market is valued at 52 Billion USD in 2018, At CAGR of 9.8% and is expected to reach 98 Billion USD by the end of 2025. Decresearch has released a brief analysis, see at on Global Infant Formula Ma...